ATE322907T1 - Plasma-albumin fraktion mit vermindertem prekallikrein - Google Patents

Plasma-albumin fraktion mit vermindertem prekallikrein

Info

Publication number
ATE322907T1
ATE322907T1 AT03767649T AT03767649T ATE322907T1 AT E322907 T1 ATE322907 T1 AT E322907T1 AT 03767649 T AT03767649 T AT 03767649T AT 03767649 T AT03767649 T AT 03767649T AT E322907 T1 ATE322907 T1 AT E322907T1
Authority
AT
Austria
Prior art keywords
fraction
reduced
precallikrein
plasma
albumine
Prior art date
Application number
AT03767649T
Other languages
English (en)
Inventor
Werner Gehringer
Katharina Pock
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32337993&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322907(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of ATE322907T1 publication Critical patent/ATE322907T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03767649T 2002-11-25 2003-11-25 Plasma-albumin fraktion mit vermindertem prekallikrein ATE322907T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026165 2002-11-25

Publications (1)

Publication Number Publication Date
ATE322907T1 true ATE322907T1 (de) 2006-04-15

Family

ID=32337993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767649T ATE322907T1 (de) 2002-11-25 2003-11-25 Plasma-albumin fraktion mit vermindertem prekallikrein

Country Status (23)

Country Link
US (1) US7700732B2 (de)
EP (1) EP1565207B1 (de)
JP (1) JP4532282B2 (de)
KR (1) KR101077651B1 (de)
CN (1) CN100364609C (de)
AT (1) ATE322907T1 (de)
AU (1) AU2003292109B2 (de)
BR (1) BR0316563A (de)
CA (1) CA2506848C (de)
DE (1) DE60304603T2 (de)
DK (1) DK1565207T3 (de)
ES (1) ES2261977T3 (de)
IL (1) IL168506A (de)
MX (1) MXPA05005328A (de)
NO (1) NO330216B1 (de)
PL (1) PL375539A1 (de)
PT (1) PT1565207E (de)
RS (1) RS20050401A (de)
RU (1) RU2321421C2 (de)
SI (1) SI1565207T1 (de)
UA (1) UA77596C2 (de)
WO (1) WO2004047859A2 (de)
ZA (1) ZA200504202B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
ES2294976B1 (es) 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
SE1050124A1 (sv) 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
GB201317458D0 (en) * 2013-10-02 2013-11-13 Spd Swiss Prec Diagnostics Gmbh Improved pregnancy test device and method
CN107216383A (zh) * 2017-07-13 2017-09-29 同路生物制药有限公司 一种人血白蛋白的制备方法及该人血白蛋白

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251510A (en) 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4378346A (en) 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4391801A (en) 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
AT376367B (de) 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT391810B (de) 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US5919907A (en) 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
US6693173B2 (en) 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins

Also Published As

Publication number Publication date
US20060100419A1 (en) 2006-05-11
WO2004047859A2 (en) 2004-06-10
ZA200504202B (en) 2006-02-22
WO2004047859A3 (en) 2004-08-05
NO20052550L (no) 2005-08-12
IL168506A (en) 2010-11-30
JP4532282B2 (ja) 2010-08-25
RU2005119987A (ru) 2006-01-20
UA77596C2 (en) 2006-12-15
PT1565207E (pt) 2006-07-31
CN1717249A (zh) 2006-01-04
EP1565207A2 (de) 2005-08-24
EP1565207B1 (de) 2006-04-12
AU2003292109B2 (en) 2009-02-05
DK1565207T3 (da) 2006-08-14
PL375539A1 (en) 2005-11-28
JP2006518705A (ja) 2006-08-17
CA2506848C (en) 2012-09-11
CA2506848A1 (en) 2004-06-10
KR101077651B1 (ko) 2011-10-27
CN100364609C (zh) 2008-01-30
NO330216B1 (no) 2011-03-07
US7700732B2 (en) 2010-04-20
BR0316563A (pt) 2005-10-04
MXPA05005328A (es) 2005-08-16
DE60304603T2 (de) 2007-02-15
SI1565207T1 (sl) 2006-08-31
ES2261977T3 (es) 2006-11-16
DE60304603D1 (de) 2006-05-24
NO20052550D0 (no) 2005-05-26
RU2321421C2 (ru) 2008-04-10
AU2003292109A1 (en) 2004-06-18
RS20050401A (en) 2007-06-04
KR20050085043A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
ATE402716T1 (de) Stabilisierte tnfr-fc formulierung mit arginin
EP1595856A4 (de) Bleifreies glasmaterial zum versiegeln, versiegelter artikel und das entsprechende versiegelungsverfahren damit
ATE382358T1 (de) Verfahren und zusammensetzungen zum sauerstofftransport mit hoher sauerstoffaffinität
EP1642871A4 (de) Bleifreies glasmaterial zum versiegeln, versiegelter artikel und versiegelungsverfahren damit
IL168506A (en) Method of manufacturing an albumin enriched plasma fraction having reduced prekallikrein activator content
DE60225897D1 (de) Kaffeezusammensetzungen mit verbesserten aromaeige
NO20051654L (no) Forlenget frigjoring av farmasoytisk preparat
EP1547975A4 (de) Verfahren zur modifizierung eines porösen films, modifizierter poröser film und verwendung davon
IS2475B (is) Nýjar 1,2,3,-setnar indólísín afleiður, hindrar af FGFS, aðferð við framleiðslu á þeim og lyfjafræðilegar samsetningar sem innihalda þau
NO20031251D0 (no) Fremgangsmåte for fremstilling av små soyabaserte måltid med lavt fett- oghöyt proteininnhold
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
ATE265810T1 (de) Nahrungsmittel oder nahrungsergänzungsmittel mit hohem energiewert, verfahren zu dessen herstellung und seine verwendungen
DE50205186D1 (de) Verfahren und Vorrichtung zur Erhitzung von in Trays eingesiegelten Fertiggerichten mit Mikrowellen
WO2003059286A3 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
ATE331735T1 (de) Verfahren zur monomerisierung von humanen serumalbumin-polymeren
ITBO20020484A0 (it) Impianto e metodo per la realizzazione di contenitori , in particolare per la conservazione di sostanze alimentari
AU2003242664A1 (en) Pasta compostions
MX9306614A (es) Composicion de metodos para la formacion de un insecticida.
ATE228767T1 (de) Verfahren und einrichtung zur konservierung von nahrungsmitteln
UA67630A (en) Method for correcting stress component in experimental model of acute adnexitis
AU7269100A (en) Method for indirectly determining the blood-clotting status
ATE321453T1 (de) Verfahren und verwendung von indol-derivaten zur verringerung des aufplatzens von obst- oder gemüsefrüchten
DE60225117D1 (de) Behältnis mit niedrigem sauerstoffgehalt, das ff-mas enthält
Li et al. P-228 SYNTHESIS AND CHARACTERIZATION OF trans-ACPD DERIVATIVES AS INHIBITORS FOR VESICULAR GLUTAMATE TRANSPORTERS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565207

Country of ref document: EP